Securities litigation in Canada

In the third edition of The Securities Litigation Review, Osler lawyers provide insight on a wide range of topics relating to securities litigation in Canada.
View the publication


Supreme Court decision in AstraZeneca v Apotex changes Canada’s patent landscape

Bradley White talks to Canadian Lawyer about the significance of this decision and why not having the promise doctrine is “one less mechanism” available in challenging the patent under 27(3) of the Patent Act.
What are the implications?

Every industry is presented with unique challenges and opportunities. With business insight across a variety of industries, we can help you tackle whatever comes your way.